[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2022.04.22.063Pharm Sci Asia 2022; 49(4), 364-371
 

Prescription of antipsychotics and prevalence of metabolic syndrome in Vietnamese inpatients with schizophrenia

Nguyen Thi Minh Thuan1*, Tran Duy Khoa1, Chau Van Tuan2

1 Biochemistry Department of Pharmacy Faculty, University of Medicine and Pharmacy at Ho Chi Minh city, Viet Nam
2 Binh Dinh Provincial Psychiatric Hospital, Viet Nam


Schizophrenia is a severe mental illness, characterized by psychotic symptoms including delusions, hallucinations, dystonia, adolescent behavior and language, and is accompanied by severe functional impairments. Antipsychotics, which are used mainly in the treatment of schizophrenia, have contributed to the development of metabolic syndrome. Studies on metabolic syndrome in schizophrenic patients have been still limited in Vietnam. The objective of this study was to investigate the prevalence of metabolic syndrome in Vietnamese inpatients with schizophrenia. The study population of this descriptive cross-sectional study was all patients with schizophrenia from September 2020 to June 2021 at Inpatient Department of Binh Dinh Provincial Psychiatric Hospital in Viet Nam. Three hundred and twelve patients who met the sampling requirements were enrolled in this study. The prevalence of schizophrenia in female patients was lower than in male patients (36.9% vs. 63.1%) in our study. The prevalence of metabolic syndrome was 30.4% (25.9% in men and 38.3% in women), more in patients ≥40 years old than in patients under 40 years old (the highest prevalence in patients ≥60 years). There was a significant relationship between age, body mass index (BMI), and duration of antipsychotic treatment with the frequency of metabolic syndrome. In conclusions, the prevalence of schizophrenia was higher in male inpatients than in female inpatients. However, the prevalence of metabolic syndrome was higher in female inpatients than male inpatients with schizophrenia, and increased with age, BMI, and duration of antipsychotic treatment.


Keyword:

Metabolic syndrome, Inpatients, Schizophrenia, Antipsychotics




Download full paper (PDF File size: 997.15 KB.)





Vol.49
No.4
July-August 2022

See other volume

 


Vol.49
No.3
May-June 2022

See other volume

 


Vol.49
No.2
March-April 2022

See other volume

 


Vol.49
No.1
January-February 2022

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2022
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.